Publications by authors named "Steven R Coats"

Claim this Profile
H
HER2-targeted antibody-drug conjugate induces host immunity against cancer stem cells.
Leiming Xia, Lu Wen, You Qin, Hannah E Dobson, Tao Zhang, Steven R Coats

Cell Chem Biol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy.
John Y Li, Samuel R Perry, Vanessa Muniz-Medina, Xinzhong Wang, Leslie K Wetzel, Steven R Coats

Cancer Cell· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy.
John Y Li, Samuel R Perry, Vanessa Muniz-Medina, Xinzhong Wang, Leslie K Wetzel, Steven R Coats

Cancer Cell· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The CEA/CD3-bispecific antibody MEDI-565 (MT111) binds a nonlinear epitope in the full-length but not a short splice variant of CEA.
Li Peng, Michael D Oberst, Jiaqi Huang, Philip Brohawn, Chris Morehouse, Steven R Coats

PLoS One· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis